ARCHIVES

In Brief: Adamson is Acting Frederick Director; Fischinger Heads Hollings Center; ASCO Has New Exec. Dir.

This article is from The Cancer Letter archive.

Vol. 19 No. 07 | February 12, 1993

Download PDF Visit The Full Archive

Related Articles

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

NCI-Approved Clinical Trials

May 30, 2003

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004

In Brief: New RFA, Program Announcements Coming Up Soon From BCDB for Radiation, Breast Cancer Studies

December 7, 1979

ASCO Honors Holland, Koop, Monaco With Special Awards

June 11, 1993